Johannes Kern

Projects

Projects per year 2021 2021 2023 2025

• 3 Finished
• 7 Active

Projects per year

Search results

• Active

  A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

  Kern, J.

  8/09/23 → 8/09/25

  Project: Research

• A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)

  Kern, J.

  1/09/23 → 31/08/25

  Project: Research

• Randomised, double-blind, placebo-controlled, Phase IIb/Phase III study to evaluate the efficacy and safety of spesolimab in patients with moderate to severe hidradenitis suppurativa. Lunsayil 1.

  Kern, J.

  24/06/23 → 24/06/25

  Project: Research

• A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBO CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NON SEGMENTAL VITILIGO

  Kern, J.

  19/05/23 → 18/05/25

  Project: Research

• A Phase 3, Randomized, 24-week,Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  Kern, J.

  10/03/23 → 10/03/25

  Project: Research

• En route to identifying peptide antigen triggers in psoriasis.

  Braun, A., Purcell, A. & Kern, J.

  1/01/23 → 31/12/25

  Project: Research

• Revealing the mechanisms of chronic pain in dystrophic EB

  Veldhuis, N., Pang, K. C., Nyström , A., Kern, J., Robertson, S. J., Edgington-Mitchell, L., Rudd, D. & Nowell, C.

  EB Research Network

  18/08/21 → 17/08/24

  Project: Research